trending Market Intelligence /marketintelligence/en/news-insights/trending/mygTLUPY7MJow4-HPazLLQ2 content esgSubNav
Log in to other products


Looking for more?

Contact Us
In This List

CytoDyn appoints chief technology officer


COVID-19 Impact & Recovery: Healthcare Outlook for H2 2021


Climate Credit Analytics: Linking climate scenarios to financial impacts


Global M&A Infographic Q1 2021


Q1 2021 Global Capital Markets Activity: SPAC IPOs, Issuance in Consumer Discretionary Sector Surge

CytoDyn appoints chief technology officer

CytoDyn Inc. has appointed Nitya Ray as the company's chief technology officer — head of process science, manufacturing and supply chain.

He was most recently executive vice president, head of product development, manufacturing and supply chain of Actinium Pharmaceuticals Inc. In addition, he was a senior vice president of Progenics Pharmaceuticals Inc.

Vancouver, Wash.-based CytoDyn is a biotechnology company developing treatments for HIV.